Luke Rothermel

11PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Accounting theory and standardsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 26, 2026
Advances in Therapeutic Melanoma Vaccines (2010-2025).

|Jun 26, 2026
The Use and Utility of Adjuvant Checkpoint Inhibitors in Elderly Patients with Melanoma: A Single Institution Experience.

|May 20, 2026
Payer-Negotiated Prices in the Diagnosis and Management of Cutaneous Melanoma in 2025.

|Apr 30, 2026
Trends in Long-Term Survival Among Patients With De Novo Metastatic Cancer.

|Dec 31, 2025
Myocarditis Mimicking Takotsubo Cardiomyopathy With First Dose of Neoadjuvant Nivolumab-Relatlimab.

Rohit Rao, Felicia Tejawinata, Tejasi Sachdeva

|Sep 30, 2024
Accounting for Socioeconomic Factors and Selection Bias That Affect Survival for Patients With Early-Stage Melanoma.

Hailey Seibert, Hanna Kakish, Jeremy S Bordeaux

Pageof 2

Frequent Collaborators

3 joint publications

Ankit Mangla

3 joint publications

Richard S Hoehn

2 joint publications

Jonathan J Hue

2 joint publications

Michael Y Bian